Karuna Therapeutics Inc. (KRTX) PT Raised to $170 at BofA Securities

March 28, 2022 8:55 AM EDT Send to a Friend
BofA Securities analyst Jason Gerberry raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $170.00 (from $157.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login